Heart Health

This article reviews available evidence regarding hypertension management in the Asia-Pacific region, focussing on five research questions that deal with specific aspects: blood pressure (BP) control, guideline recommendations, role of renin–angiotensin–aldosterone system (RAAS) inhibitors in clinical practice, pharmacological management and real-world adherence to guideline recommendations.

The goal of this article is to characterize the endothelium’s role in the development of hypertension and dyslipidemia and to point out promising therapeutic directions.

This study aimed to assess the proportion and trends of Asian race participants and APAC authorship in cardiometabolic trials.

The Asian Pacific Society of Cardiology (APSC) developed these consensus recommendations to address the need for a unified approach to managing dyslipidaemia. These recommendations are intended to guide general cardiologists and internists in the assessment and treatment of dyslipidaemia and are hoped to pave the way for improving screening, early diagnosis and treatment.

A systematic review aiming to assess the prevalence of hypertension and its risk factors among the urban population in Southeast Asian countries was conducted. We performed database searches of PubMed and Web of Science and performed meta-analysis to determine the pooled prevalence estimate.

The aim of this review is to highlight the fundamental aspects of the diagnostic criteria, pathophysiology, and the treatment of the dyslipidemia in cardiometabolic syndrome.

Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent
meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged 75 years, using unattended automated office BP measurement.